FDA Letter API

WD Import and Export Inc.

Letter data

Company
WD Import and Export Inc.
Recipient
WD Import and Export Inc. | United States
Issue date
2018-02-13
Posted date
Not available
FDA office
United States
Subject
Not available
Product
Not available
CMS ID
516144
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER WD Import and Export Inc. MARCS-CMS 516144 — February 13, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Recipient: WD Import and Export Inc. United States Issuing Office: United States Office of Regulatory Affairs Office of Enforcement and Import Operations Division of Northeast Imports February 13, 2018 Mr. Chien Chen Wang, Owner WD Import and Export, Inc. 4703 2nd Avenue Brooklyn, NY 11232-4218 Dear Mr. Wang: The Food & Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter NYK-2017-4, dated January 26, 2017. Based on our evaluation it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Slater K. Bartlett Acting Compliance Officer Division of Northeast Imports-Compliance Branch Content current as of: 02/16/2018